Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

NCT00958256 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

M.D. Anderson Cancer Center

Collaborators